US Site
Alcon Site Directory
Patients and Caregivers
Our Science
Nuclear Medicine
Our Pipeline
Clinical Trials
Careers
Our Business
Radioligand Therapy
Molecular Imaging
History
Ethics, Risk and Compliance
External Funding
Our Products
Contact Us
English
Deutsch
(
German
)
Français
(
French
)
Italiano
(
Italian
)
Español
(
Spanish
)
Novartis resumes production and delivery of radioligand therapy medicines ahead of schedule
ENG
×
Work in progress